Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Post-Covid-19 Hemostatic Characteristics of Convalescent Patients: The Bergamo Experience

Carmen Julia J Tartari, Giulia Milani, Francesco Salvetti, Marina Marchetti, Laura Russo, Alfonso Vignoli, Massimiliano Vitali, Francesca Schieppati, Giulia Ravasio, Laura Castellani, Eleonora Sanga, Debora Romeo, Anna Falanga

Blood (2021) 138 (Supplement 1): 1054.

https://doi.org/10.1182/blood-2021-153611

Published: 2021

Journal Articles

Thrombin Generation and D-Dimer Significantly Predict for Early Disease Progression and Mortality in Patients with Gastrointestinal Cancer

Blood (2020) 136 (Supplement 1): 32.

https://doi.org/10.1182/blood-2020-136631

Published: 2020

Journal Articles

A Thrombotic Biomarker-Based Risk Assessment Scoring Model for Disease Recurrence in Breast Cancer Patient Candidate to Systemic Chemotherapy

Blood (2019) 134 (Supplement_1): 2426.

https://doi.org/10.1182/blood-2019-129820

Published: 2019

Journal Articles

Thrombotic Risk Assessment in a Prospective Cohort of Newly Diagnosed Ambulatory Cancer Patients Candidate to Chemotherapy

Blood (2019) 134 (Supplement_1): 3642.

https://doi.org/10.1182/blood-2019-129901

Published: 2019

Journal Articles

Hypercoagulation Screening as Marker of Occult Cancer in a Population of Healthy Blood Donors: The Hypercan Prospective Study

Anna Falanga, MD, Marina Marchetti, MSc, PhD, Sara Gamba, MSc, Laura Russo, MSc, Carmen Julia Tartari, MSc, PhD, Cinzia Giaccherini, MSc, Cristina Verzeroli, MSc, Francesca Piras, MSc, Viola Milesi, MD, Alfonso Vignoli, MSc, Shenaz Brevi, Francesca Rio, Luca Barcella, MD, Giuseppe Sampietro

Blood (2016) 128 (22): 2604.

https://doi.org/10.1182/blood.V128.22.2604.2604

Published: 2016

Journal Articles

JAK2V617F Mutation and Thrombosis History Are Determinants of Mean Platelet Volume (MPV) in Essential Thrombocythemia Patients

Marina Marchetti, MSc, PhD, Cristina Verzeroli, MSc, Cinzia Giaccherini, MSc, Sara Gamba, MSc, Alfonso Vignoli, MSc, Laura Russo, MSc, Guido Finazzi, MD, Alessandro Rambaldi, MD, Anna Falanga, MD

Blood (2016) 128 (22): 2606.

https://doi.org/10.1182/blood.V128.22.2606.2606

Published: 2016

Journal Articles

Effects of Antiplatelet Treatment with Aspirin (ASA) on Platelet Reactivity in Patients with Essential Thrombocythemia

Marina Marchetti, MSc, PhD, Sara Gamba, MSc, Cinzia Giaccherini, MSc, Cristina Verzeroli, MSc, Laura Russo, MSc, Carmen Julia Tartari, MSc, PhD, Alfonso Vignoli, MSc, Guido Finazzi, MD, Alessandro Rambaldi, MD, Anna Falanga, MD

Blood (2016) 128 (22): 4253.

https://doi.org/10.1182/blood.V128.22.4253.4253

Published: 2016

Journal Articles

Platelet Adhesion Under Flow Condition in Patients with Essential Thrombocythemia (ET) and Polycythemia Vera (PV): Analysis According to the Mutational Status

Alfonso Vignoli, MSc, Serena Tessarolo, MSc, Marina Marchetti, MSc, PhD, Sara Gamba, MSc, Francesca Piras, MSc, Guido Finazzi, MD, Paola van der Meijden, PhD, Frauke Swieringa, PhD, Hugo ten Cate, MD PhD, Johan Heemskerk, PhD, Alessandro Rambaldi, MD, Anna Falanga, MD

Blood (2015) 126 (23): 766.

https://doi.org/10.1182/blood.V126.23.766.766

Published: 2015

Journal Articles

Measurement of Thrombin Generation Is a Positive Predictive Biomarker of V enous Thromboembolism ( VTE) in Metastatic Cancer Patients Enrolled in the Hypercan Study

Blood (2015) 126 (23): 654.

https://doi.org/10.1182/blood.V126.23.654.654

Published: 2015

Journal Articles

Hypercoagulation Screening As a Marker of Thrombosis and Poor Disease Prognosis in Cancer Patients: The Hypercan Prospective Study

Marina R Marchetti, PhD, Giovanna Masci, MD, Armando Santoro, MD, Filippo de Braud, MD, Luigi Celio, MD, Roberto Labianca, MD, Mario Mandalà, MD, Barbara Merelli, MD, Carlo Tondini, MD, Giampietro Gasparini, MD, Roberta Sarmiento, MD, Carmen J Tartari, PhD, Cinzia Giaccherini, MBioSc, Francesca Piras, MBioSc, Cristina Verzeroli, MBioSc, Luca Barcella, MD, Alfonso Vignoli, MBioSc, Anna Falanga, MD

Blood (2014) 124 (21): 586.

https://doi.org/10.1182/blood.V124.21.586.586

Published: 2014

Journal Articles

Increased Platelet Thrombus Formation Under Flow Condition In Myeloproliferative Neoplasms (MPN)

Alfonso Vignoli, Paola van der Meijden, Marina Marchetti, Cinzia Giaccherini, Serena Tessarolo, Frauke Swieringa, Hugo ten Cate, Guido Finazzi, Alessandro Rambaldi, MD, Johan Heemskerk, PhD, Anna Falanga

Blood (2013) 122 (21): 33.

https://doi.org/10.1182/blood.V122.21.33.33

Published: 2013

Journal Articles

Very Low Molecular Weight Heparins Retain the Capacity to Inhibit Endothelial Cell Migration and Capillary-Like Tube Formation Induced by Tumor Cells.

Marina Marchetti, Alfonso Vignoli, Elena Cantalino, Erika Diani, Gaia Bonacina, Anna Falanga, MD

Blood (2009) 114 (22): 3047.

https://doi.org/10.1182/blood.V114.22.3047.3047

Published: 2009

Journal Articles

Impact of V617F JAK2 Mutation on Monocyte Tissue Factor and Procoagulant Activity in Patients with Essential Thrombocythemia(ET) or Polycythemia VERA (PV)

Anna Falanga, MD, Alfonso Vignoli, Marina Marchetti, Laura Russo, Marina Panova-Noeva, Donatella Balducci, Silvia Salmoiraghi, Tiziano Barbui, Hugo ten Cate, Alessandro Rambaldi

Blood (2008) 112 (11): 3736.

https://doi.org/10.1182/blood.V112.11.3736.3736

Published: 2008

Journal Articles

Distinct Hemostatic Profile of Leukocytes in Essential Thrombocythemia (ET) Carrying the JAK2 V617F Mutation.

Anna Falanga, MD, Marina Marchetti, BSc, PhD, Donatella Balducci, BSc, Alfonso Vignoli, BSc, Laura Russo, BSc, Vittoria Guerini, BSc, Alessandro Rambaldi, MD, Tiziano Barbui, MD

Blood (2005) 106 (11): 378.

https://doi.org/10.1182/blood.V106.11.378.378

Published: 2005

Journal Articles

Inhibition of Breast Cancer and Leukemia Cell-Induced Endothelial Angiogenesis by Low Molecular Weight Heparins (LMWH).

Marina Marchetti, PhD, Alfonso Vignoli, BSc, Marcella Pagnoncelli, BSc, Anna Falanga, MD

Blood (2004) 104 (11): 2615.

https://doi.org/10.1182/blood.V104.11.2615.2615

Published: 2004

Journal Articles

Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera

Anna Falanga, Marina Marchetti, Virgilio Evangelista, Alfonso Vignoli, Marina Licini, Mara Balicco, Stefano Manarini, Guido Finazzi, Chiara Cerletti, Tiziano Barbui

Blood (2000) 96 (13): 4261–4266.

https://doi.org/10.1182/blood.V96.13.4261

Published: 2000

NARROW

Post-Covid-19 Hemostatic Characteristics of Convalescent Patients: The Bergamo Experience

Thrombin Generation and D-Dimer Significantly Predict for Early Disease Progression and Mortality in Patients with Gastrointestinal Cancer

A Thrombotic Biomarker-Based Risk Assessment Scoring Model for Disease Recurrence in Breast Cancer Patient Candidate to Systemic Chemotherapy

Thrombotic Risk Assessment in a Prospective Cohort of Newly Diagnosed Ambulatory Cancer Patients Candidate to Chemotherapy

Hypercoagulation Screening as Marker of Occult Cancer in a Population of Healthy Blood Donors: The Hypercan Prospective Study

JAK2V617F Mutation and Thrombosis History Are Determinants of Mean Platelet Volume (MPV) in Essential Thrombocythemia Patients

Effects of Antiplatelet Treatment with Aspirin (ASA) on Platelet Reactivity in Patients with Essential Thrombocythemia

Platelet Adhesion Under Flow Condition in Patients with Essential Thrombocythemia (ET) and Polycythemia Vera (PV): Analysis According to the Mutational Status

Measurement of Thrombin Generation Is a Positive Predictive Biomarker of V enous Thromboembolism ( VTE) in Metastatic Cancer Patients Enrolled in the Hypercan Study

Hypercoagulation Screening As a Marker of Thrombosis and Poor Disease Prognosis in Cancer Patients: The Hypercan Prospective Study

Increased Platelet Thrombus Formation Under Flow Condition In Myeloproliferative Neoplasms (MPN)

Very Low Molecular Weight Heparins Retain the Capacity to Inhibit Endothelial Cell Migration and Capillary-Like Tube Formation Induced by Tumor Cells.

Impact of V617F JAK2 Mutation on Monocyte Tissue Factor and Procoagulant Activity in Patients with Essential Thrombocythemia(ET) or Polycythemia VERA (PV)

Distinct Hemostatic Profile of Leukocytes in Essential Thrombocythemia (ET) Carrying the JAK2 V617F Mutation.

Inhibition of Breast Cancer and Leukemia Cell-Induced Endothelial Angiogenesis by Low Molecular Weight Heparins (LMWH).

Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only